GSK2879552 dihydrochloride
CAS No. 1902123-72-1
GSK2879552 dihydrochloride ( ——— )
产品货号. M38014 CAS No. 1902123-72-1
GSK2879552 dihydrochloride an orally active, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1/KDM1A), with potential antineoplastic activity.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | 获取报价 | 有现货 |
|
| 25MG | 获取报价 | 有现货 |
|
| 50MG | 获取报价 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GSK2879552 dihydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述GSK2879552 dihydrochloride an orally active, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1/KDM1A), with potential antineoplastic activity.
-
产品描述GSK2879552 dihydrochloride an orally active, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1/KDM1A), with potential antineoplastic activity.
-
体外实验GSK2879552 dihydrochloride (1.5 mg/kg,po) 处理在携带 SCLC 异种移植物的小鼠中表现出肿瘤生长抑制。Animal Model:NCI-H526 and NCI-H1417 xenografts.Dosage:1.5 mg/kg.Administration:PO daily for 25-35 days.Result:There was 57% and 83% tumor growth inhibition (TGI) in NCI-H526 and NCI-H1417 tumor bearing mice respectively. NCI-H510 and NCI-H69 tumor bearing mice also demonstrated partial TGI (38% and 49% respectively) in response to GSK2879552, while no significant TGI was observed for SHP77 bearing mice.
-
体内实验GSK2879552 dihydrochloride 抑制 KDM1A 组蛋白去甲基化酶活性,诱导索拉非尼耐药细胞的分化并减弱干细胞特性。GSK2879552 dihydrochloride 在索拉非尼耐药细胞中抑制 Wnt 拮抗剂的转录并下调 β-catenin 信号活性。Cell Viability Assay.Cell Line:9/28 small cell lung carcinoma (SCLC) lines and 20/29 AML lines. Concentration:0-10000 nM.Incubation Time:6 days.Result:Inhibited cell proliferation.RT-PCR.Cell Line:Resistant HCC cells (PLC/PRF/5 and Huh7).Concentration:0, 1, 2 μM.Incubation Time:24 h.Result:Displayed reduced mRNA expression levels of stem cell markers, such as Lgr5, Sox9,Nanog and CD90, and elevated mRNA expression levels of differentiation markers Alb and Hnf4.
-
同义词———
-
通路Others
-
靶点Other Targets
-
受体KDM1/LSD1
-
研究领域———
-
适应症———
化学信息
-
CAS Number1902123-72-1
-
分子量437.4
-
分子式C23H30Cl2N2O2
-
纯度>98% (HPLC)
-
溶解度H2O : 100 mg/mL (228.62 mM) DMSO : 31.25 mg/mL (71.44 mM)
-
SMILES———
-
化学全称———
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Huang M, et al. Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma. Cancer Lett. 2017 Apr 2;398:12-21.?
产品手册
关联产品
-
Neuromedin N
Neuromedin N is a neuropeptide derived from the same precursor polypeptide as neurotensin, and with similar but subtly distinct expression and effects.
-
Stiripentol
Stiripentol (STP) 是一种抗惊厥药,可抑制 CYP3A4(非竞争性)和 CYP2C19(竞争性)介导的 CLB N-去甲基化为 NCLB,Ki 为 1.59/0.516 μM,IC50 为 1.58/3.29 μM。
-
Tulathromycin B
Tulathromycin B (CP 547272) 是 Tulathromycin (一种大环内酯类抗生素) 的异构体
021-51111890
购物车()
sales@molnova.cn

